Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Jul 14, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool called the Computerized Symptom Assessment Tool (C-SCAT) to see if it can help young people with cancer better manage their symptoms. The goal is to compare how well this tool works against the usual care that patients receive. The trial will focus on whether using C-SCAT can boost participants' confidence in handling their symptoms and improve how they manage them day-to-day.
To be eligible for the study, participants must be between 5 and 18 years old, have started cancer treatment within the last three months, and be scheduled to continue receiving treatment for at least three more cycles. They should also be experiencing at least one symptom related to their cancer or its treatment and be able to read, write, and speak English. If someone joins the study, they can expect to use the C-SCAT tool, which will help them track their symptoms and learn how to manage them better. This trial is currently looking for participants, and it's a chance for young patients to receive additional support during their treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has received at least 1 cycle of cancer treatment and is within 3 months of initial cancer diagnosis
- • Receiving regularly scheduled cancer treatment and will be receiving at least three more cycles
- • Reports at least 1 symptom related to cancer and/or its treatment
- • Able to speak, read, and write English as required for completion of the C-SCAT and study measures
- Exclusion Criteria:
- • - Cognitive and/or physical inability to complete study measures.
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Richmond, Virginia, United States
Salt Lake City, Utah, United States
Seattle, Washington, United States
Patients applied
Trial Officials
Ronald Elswick, PhD
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported